ClinicaliQ Trial Snapshot
- A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) — Recruiting • Phase I • Respiratory / COPD / Asthma • NCT06649110.
- What is being tested: LTP001 is a novel investigational treatment being evaluated in a two-part study: Part A assesses safety and tolerability in healthy volunteers, while Part B evaluates efficacy and safety in patients with pulmonary arterial hypertension (PAH).
- Patient eligibility overview: Part A enrolls healthy adult participants with normal cardiac and pulmonary function; Part B recruits patients with confirmed PAH diagnosis, typically requiring stable disease status and specific haemodynamic criteria to ensure homogeneous study populations.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
Eligibility Snapshot
- Part A Inclusion Criteria: * Healthy males and non-child-bearing potential females Part A
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.